These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9715603)

  • 1. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

  • 2. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK; Cherian A
    Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immune reconstitution inflammatory syndrome and HIV leprosy co-infection].
    Manga NM; Poda A; Bazolo N; Sané O; Batista G; Guèye NF; Sow PS; Badiane CI
    Med Mal Infect; 2011 Jul; 41(7):390-1. PubMed ID: 21458936
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India.
    Lockwood DN; Vinayakumar S; Stanley JN; McAdam KP; Colston MJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):8-15. PubMed ID: 8326184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leprosy in five human immunodeficiency virus-infected patients.
    Moran CA; Nelson AM; Tuur SM; Luengu M; Fonseca L; Meyers WM
    Mod Pathol; 1995 Aug; 8(6):662-4. PubMed ID: 8532702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leprosy reactions. New knowledge.
    Naafs B
    Trop Geogr Med; 1994; 46(2):80-4. PubMed ID: 8079395
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemoimmunotherapy: its relevance in contemporary context.
    Sehgal VN; Jain S
    Int J Dermatol; 1994 Oct; 33(10):753-4. PubMed ID: 8002151
    [No Abstract]   [Full Text] [Related]  

  • 10. Enthesopathy in leprosy.
    Carpintero-Benítez P; Logroño C; Collantes-Estevez E
    J Rheumatol; 1996 Jun; 23(6):1020-1. PubMed ID: 8782134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve damage in leprosy.
    Job CK
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):532-9. PubMed ID: 2545801
    [No Abstract]   [Full Text] [Related]  

  • 12. Ulnar abscess: 4 months after release from control with paucibacillary-multidrug therapy.
    Darius EJ; Selvasekar A; Mani MN; Jesudasan K
    Lepr Rev; 1997 Jun; 68(2):173-4. PubMed ID: 9217358
    [No Abstract]   [Full Text] [Related]  

  • 13. Fulminant hepatic failure in a 15 year old boy with borderline lepromatous leprosy and type 2 reaction.
    Mendiratta V; Malik M; Gurtoo A; Chander R
    Lepr Rev; 2014 Mar; 85(1):54-7. PubMed ID: 24974443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy - an overview of clinical features, diagnosis, and treatment.
    Fischer M
    J Dtsch Dermatol Ges; 2017 Aug; 15(8):801-827. PubMed ID: 28763601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculous lymphadenitis and borderline leprosy in a patient with isolated unconjugated hyperbilirubinaemia.
    Magazine R; Chogtu B; Manu MK; Shahul HA
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25385559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A florid case of borderline-lepromatous leprosy.
    Raman J; Fisher D
    Med J Aust; 1988 Dec 5-19; 149(11-12):701-2. PubMed ID: 3200196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levels of IgG subclasses in active and inactive cases in the disease spectrum of leprosy.
    Beuria MK; Parkash O; Joshi B; Mohanty KK; Katoch K; Sengupta U
    Int Arch Allergy Immunol; 1998 Jan; 115(1):61-6. PubMed ID: 9430497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An investigation of mast cells in two basic leprosy groups.
    Aroni K; Kontochristopoulos G; Liossi A; Panteleos D
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):634-5. PubMed ID: 8151199
    [No Abstract]   [Full Text] [Related]  

  • 20. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.